L-GAM, a long-term oriented investment firm, and French Tech Souverainete, an investment fund, agreed to invest €80m ($86m) in Biose Industrie, a contract development and manufacturing organization, specialized in Live biotherapeutic products. "As an industrial partner naturally intent on serving our clients, we are proud to contribute with them to improving the health of all the patients affected by their research programmes,” Adrien Nivoliez, Biose Industrie CEO.